Target- |
Mechanism- |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
以安慰剂为对照评价前列宝颗粒治疗慢性前列腺炎湿热兼阴虚证有效性和安全性的随机、双盲、多中心临床研究
[Translation] A randomized, double-blind, multicenter clinical study using placebo as control to evaluate the efficacy and safety of Qianliebao granules in the treatment of chronic prostatitis with damp-heat and yin deficiency syndrome
以安慰剂为对照评价前列宝颗粒治疗慢性前列腺炎湿热兼阴虚证的有效性、安全性
[Translation] Evaluation of the efficacy and safety of Qianliebao granules in the treatment of chronic prostatitis with damp-heat and yin deficiency using placebo as control
100 Clinical Results associated with Guangdong Kangping Pharmaceutical Innovation Technology Development Co., Ltd.
0 Patents (Medical) associated with Guangdong Kangping Pharmaceutical Innovation Technology Development Co., Ltd.
100 Deals associated with Guangdong Kangping Pharmaceutical Innovation Technology Development Co., Ltd.
100 Translational Medicine associated with Guangdong Kangping Pharmaceutical Innovation Technology Development Co., Ltd.